Corvus Pharmaceuticals, Inc. (CRVS)
20.40
-0.06
(-0.29%)
USD |
NASDAQ |
Feb 09, 16:00
20.06
-0.34
(-1.67%)
After-Hours: 16:56
Corvus Pharmaceuticals Total Assets (Quarterly) : 80.47M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Plus Therapeutics, Inc. | 18.67M |
| Geron Corp. | 567.38M |
| Jaguar Health, Inc. | 49.47M |
| Krystal Biotech, Inc. | 1.240B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.706M |
| Shareholders Equity (Quarterly) | 71.77M |
| Debt to Equity Ratio | 0.0141 |
| Current Ratio | 8.291 |
| Net Debt Paydown Yield | -0.01% |